MedPath

Imagery Rescripting for Obsessive Compulsive Disorder, Body Dysmorphic Disorder and Early Psychosis: a Multiple-Baseline Single-Case Experimental Design.

Phase 3
Conditions
Obsessive Compulsive Disorder AND Body Dysmorphic Disorder AND Psychosis
10002861
Registration Number
NL-OMON53763
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
41
Inclusion Criteria

• Meet the criteria for OCD, BDD or psychosis, a primary diagnosis according to
the Diagnostic and Statistical Manual of Mental Disorders (5th ed; American
Psychiatric Association, 2013)
• Are aged 18 and beyond
• Dutch literacy
• Cut-off Y-BOCS of 20 (not eligible for psychosis)
• No change in medication. Stable dose at least 6 weeks prior to study (not
eligible for psychosis)

Exclusion Criteria

• Current (hypo)mania
• Psychotic disorder (excluding delusional symptoms related to disorder) (not
eligible for psychose)
• Alcohol or drugs abuse as diagnosed by DSM-5
• Electroconvulsive therapy in last 6 months
• Neurological disorder or IQ< 80

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Primary outcomes<br /><br>- Schema or core beliefs, as measured by VAS scales.<br /><br>- OCD and BDD core symptoms (based on the Y-BOCS, as measured by VAS scales)<br /><br>- Well-being (MHQoL) and self-esteem (RSES) (Psychosis)</p><br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath